Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
出版年份 2018 全文链接
标题
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
作者
关键词
-
出版物
DIABETOLOGIA
Volume 61, Issue 12, Pages 2461-2498
出版商
Springer Nature America, Inc
发表日期
2018-10-04
DOI
10.1007/s00125-018-4729-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
- (2018) Jean-Daniel Lalau et al. DIABETES CARE
- Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
- (2018) Kamlesh Khunti et al. DIABETES OBESITY & METABOLISM
- Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
- (2018) Francesco Zaccardi et al. DIABETES OBESITY & METABOLISM
- Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis
- (2018) Panagiotis Andreadis et al. DIABETES OBESITY & METABOLISM
- A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials
- (2018) Carolyn F. Deacon DIABETES OBESITY & METABOLISM
- Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis
- (2018) Emma Sainsbury et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
- (2018) Rohan Khera et al. GASTROENTEROLOGY
- The effect of nurse prescribers on glycaemic control in type 2 diabetes: A systematic review and meta -analysis
- (2018) Maryam Tabesh et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
- Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study
- (2018) Sayeed Ikramuddin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes
- (2018) Kasia J. Lipska et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
- (2018) Xin‐Lin Zhang et al. Journal of the American Heart Association
- Optimisation of follow-up after metabolic surgery
- (2018) Geltrude Mingrone et al. Lancet Diabetes & Endocrinology
- Do sulphonylureas still have a place in clinical practice?
- (2018) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Diabetes structured self-management education programmes: a narrative review and current innovations
- (2018) Sudesna Chatterjee et al. Lancet Diabetes & Endocrinology
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis
- (2017) Carol H. Wysham et al. POSTGRADUATE MEDICINE
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Clinical inertia—Time to reappraise the terminology?
- (2017) Kamlesh Khunti et al. Primary Care Diabetes
- Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial
- (2017) Jo-Anne Manski-Nankervis et al. Primary Care Diabetes
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings
- (2017) Laura A. Young et al. JAMA Internal Medicine
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
- (2017) Sultan Linjawi et al. Diabetes Therapy
- A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
- (2017) Sultan Linjawi et al. Diabetes Therapy
- Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
- (2017) Philip A Levin et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis
- (2017) Shaun Wen Huey Lee et al. Scientific Reports
- What Is Shared Decision Making? (and What It Is Not)
- (2016) Marleen Kunneman et al. ACADEMIC EMERGENCY MEDICINE
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials
- (2016) Labib Imran Faruque et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
- (2016) Luc Van Gaal et al. DIABETES CARE
- Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes
- (2016) Ivan Tkáč et al. DIABETES CARE
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
- (2016) Francesco Rubino et al. DIABETES CARE
- Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
- (2016) Julio Rosenstock et al. DIABETES CARE
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
- (2016) Vanita R. Aroda et al. DIABETES CARE
- Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2016) Huilin Tang et al. DIABETES CARE
- Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
- (2016) Sonal Singh et al. DIABETES OBESITY & METABOLISM
- Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)
- (2016) V. R. Aroda et al. DIABETES OBESITY & METABOLISM
- A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
- (2016) Mirna S. Abd El Aziz et al. DIABETES OBESITY & METABOLISM
- Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials
- (2016) Dandan Li et al. DIABETES OBESITY & METABOLISM
- Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial
- (2016) R. Aronson et al. DIABETES OBESITY & METABOLISM
- Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
- (2016) Huilin Tang et al. DIABETES OBESITY & METABOLISM
- Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
- (2016) Crystal Man Ying Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: A systematic review and meta-analysis
- (2016) Lee-Wen Pai et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis
- (2016) Se Hee Min et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
- (2016) Peter Gæde et al. DIABETOLOGIA
- Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases
- (2016) Annamaria Mascolo et al. DRUG SAFETY
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
- (2016) Anders Jorsal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery
- (2016) Aaron J. Dawes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2016) Fang-Fang Zhao et al. JOURNAL OF ADVANCED NURSING
- Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
- (2016) Catherine M. Viscoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
- (2016) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes
- (2016) Patrick M. O'Neil et al. Obesity
- Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control
- (2016) Carole A. Chrvala et al. PATIENT EDUCATION AND COUNSELING
- Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
- (2016) Zhixia Li et al. PLoS One
- Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
- (2016) Sylvie Erpeldinger et al. BMC Endocrine Disorders
- Effects of yoga in adults with type 2 diabetes mellitus: A meta-analysis
- (2016) Jie Cui et al. Journal of Diabetes Investigation
- Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
- (2016) Carola A Huber et al. Patient Preference and Adherence
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol
- (2016) Andrew McGovern et al. BMJ Open
- Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
- (2016) Nick Freemantle et al. BMJ Open
- Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
- (2016) Francesco Salvo et al. BMJ-British Medical Journal
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
- (2016) Robert G. Moses et al. Journal of Diabetes
- Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
- (2016) Francesco Salvo et al. BMJ-British Medical Journal
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- The changing face of diabetes complications
- (2016) Edward W Gregg et al. Lancet Diabetes & Endocrinology
- Shared decision making in endocrinology: present and future directions
- (2016) Rene Rodriguez-Gutierrez et al. Lancet Diabetes & Endocrinology
- Barriers and Facilitators to the Uptake and Maintenance of Healthy Behaviours by People at Mid-Life: A Rapid Systematic Review
- (2016) Sarah Kelly et al. PLoS One
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments
- (2015) Francesco Zaccardi et al. ANNALS OF INTERNAL MEDICINE
- Behavioral Programs for Type 2 Diabetes Mellitus
- (2015) Jennifer Pillay et al. ANNALS OF INTERNAL MEDICINE
- Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes
- (2015) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics
- (2015) Margaret A. Powers et al. DIABETES CARE
- Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)
- (2015) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT
- (2015) M. A. Abdul-Ghani et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2015) T. Karagiannis et al. DIABETES OBESITY & METABOLISM
- One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial
- (2015) S. C. L. Gough et al. DIABETES OBESITY & METABOLISM
- Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data
- (2015) S. Del Prato et al. DIABETES OBESITY & METABOLISM
- One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
- (2015) M. C. Riddle et al. DIABETES OBESITY & METABOLISM
- Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial
- (2015) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
- (2015) A Ram Hong et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis
- (2015) Basem M. Mishriky et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents
- (2015) Siew Pheng Chan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis
- (2015) E. S. Mearns et al. DIABETIC MEDICINE
- Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2015) C. Wang et al. DIABETIC MEDICINE
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
- (2015) Pablo Aschner et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The eHealth Enhanced Chronic Care Model: A Theory Derivation Approach
- (2015) Perry M Gee et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
- (2015) Geltrude Mingrone et al. LANCET
- A systematic review and meta-analysis of tai chi for treating type 2 diabetes
- (2015) Myeong Soo Lee et al. MATURITAS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
- (2015) D. Russell-Jones et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Improving diabetes outcomes through lifestyle change - A randomized controlled trial
- (2015) Linda M. Delahanty et al. Obesity
- Lifestyle Weight-Loss Intervention Outcomes in Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2015) Marion J. Franz et al. Journal of the Academy of Nutrition and Dietetics
- Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
- (2015) Martin J. Downes et al. PeerJ
- Longitudinal Effects of Medication Nonadherence on Glycemic Control
- (2014) Leonard E. Egede et al. ANNALS OF PHARMACOTHERAPY
- Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials
- (2014) Shanhu Qiu et al. BMC Medicine
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- The Effects of a Mediterranean Diet on the Need for Diabetes Drugs and Remission of Newly Diagnosed Type 2 Diabetes: Follow-up of a Randomized Trial
- (2014) Katherine Esposito et al. DIABETES CARE
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)
- (2014) Matthew C. Riddle et al. DIABETES CARE
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)
- (2014) Hannele Yki-Järvinen et al. DIABETES CARE
- Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
- (2014) Lawrence A. Leiter et al. DIABETES CARE
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study
- (2014) S. Del Prato et al. DIABETES OBESITY & METABOLISM
- Is insulin the most effective injectable antihyperglycaemic therapy?
- (2014) J. B. Buse et al. DIABETES OBESITY & METABOLISM
- A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes
- (2014) M. Monami et al. DIABETES OBESITY & METABOLISM
- Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis
- (2014) Lukas Schwingshackl et al. DIABETOLOGIA
- Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis
- (2014) R Huo et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
- (2014) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin in Patients With Type 2 Diabetes and Kidney Disease
- (2014) Silvio E. Inzucchi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
- (2014) Julio Rosenstock et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
- (2014) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis
- (2014) Shanhu Qiu et al. PLoS One
- Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
- (2014) K. Esposito et al. BMJ Open
- Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
- (2014) Martin Ridderstråle et al. Lancet Diabetes & Endocrinology
- Results of a reevaluation of cardiovascular outcomes in the RECORD trial
- (2013) Kenneth W. Mahaffey et al. AMERICAN HEART JOURNAL
- Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes
- (2013) Olubukola Ajala et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes
- (2013) Katherine Esposito ANNALS OF INTERNAL MEDICINE
- Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2013) Erin S. LeBlanc et al. ANNALS OF INTERNAL MEDICINE
- Screening for and Management of Obesity in Adults: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
- (2013) Richard G. Bach et al. CIRCULATION
- A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
- (2013) R. G. Moses et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
- (2013) V. Lukashevich et al. DIABETES OBESITY & METABOLISM
- Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
- (2013) O. J. Phung et al. DIABETES OBESITY & METABOLISM
- The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
- (2013) Paweł Kawalec et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials
- (2013) Yifei Zhang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
- (2013) J. A. Hirst et al. DIABETOLOGIA
- Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes
- (2013) Melinda Maggard-Gibbons et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society fo
- (2013) Jeffrey I. Mechanick et al. Obesity
- Resistance Exercise Versus Aerobic Exercise for Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2013) Zuyao Yang et al. SPORTS MEDICINE
- Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
- (2013) Helena W Rodbard et al. Lancet Diabetes & Endocrinology
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
- (2012) Vanita R. Aroda et al. CLINICAL THERAPEUTICS
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
- (2012) R. R. Henry et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
- (2012) Geltrude Mingrone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Substance Use Following Bariatric Weight Loss Surgery
- (2012) Alexis Conason et al. JAMA Surgery
- Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes: A meta-analysis
- (2011) A. Chudyk et al. DIABETES CARE
- Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial
- (2011) Susan A Jebb et al. LANCET
- Effect of an Intensive Exercise Intervention Strategy on Modifiable Cardiovascular Risk Factors in Subjects With Type 2 Diabetes MellitusA Randomized Controlled Trial: The Italian Diabetes and Exercise Study (IDES)Intensive Exercise and Modifiable CV Risk Factors
- (2010) Stefano Balducci ARCHIVES OF INTERNAL MEDICINE
- Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
- (2010) L. Azadbakht et al. DIABETES CARE
- The Diabetes Mellitus Medication Choice Decision Aid
- (2009) Rebecca J. Mullan et al. ARCHIVES OF INTERNAL MEDICINE
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIATRIC SURGERY PATIENT
- (2009) Jeffrey I. Mechanick et al. Obesity
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes
- (2008) John B. Dixon et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
- (2008) Iris Shai et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes
- (2008) Maggie Breslin et al. PATIENT EDUCATION AND COUNSELING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now